Acquiring Company
Blue Matter
Acquired Company
Cognite
Greater LondonBiotechnologyHealth CareDescription
Blue Matter, a life sciences consulting firm, announced the acquisition of Cognite, a healthcare communications agency. The deal strengthens Blue Matter's communications capabilities for biopharma clients. Financial terms were not disclosed, and Blue Matter is a portfolio company of Baird Capital.
Who to call at Blue Matter, and when
When Blue Matter changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Blue Matter raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Blue Matter, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Blue Matter. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Blue Matter makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Cognite?
Cognite was acquired by Blue Matter. The deal was reported on October 28, 2026. Blue Matter is a world-class consulting firm serving the life sciences industry. The firm works with pharmaceutical and biotech clients. Blue Matter is privately held.
When did Blue Matter acquire Cognite?
Blue Matter's acquisition of Cognite was reported on October 28, 2026. Blue Matter, a life sciences consulting firm, announced the acquisition of Cognite, a healthcare communications agency. The deal strengthens Blue Matter's communications capabilities for biopharma clients. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Cognite do?
Cognite is a leading global healthcare communications agency. It helps pharmaceutical and biotech companies bring science to life through scientific, medical, and commercial communications services. It is privately held, operating in Biotechnology, and is based in Greater London.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.